Featured Transcriptomics & Genomic Products
Explore our leading sequencing services tailored for research institutions, universities, and industries across Kuala Lumpur and the wider Klang Valley.
Unlocking Directional Transcriptomics: The Power of Stranded mRNA-Seq
In traditional RNA sequencing, the information regarding the strand orientation of the original RNA transcript is lost during the second-strand cDNA synthesis. Stranded mRNA-Seq (also known as directional RNA-Seq) overcomes this limitation by preserving the strand-of-origin information. By utilizing the dUTP second-strand marking method, researchers can accurately identify which of the two complementary DNA strands was transcribed.
This directional information is vital for several advanced genomic analyses, including:
- Accurate Gene Expression Quantification: Correctly assigning reads to overlapping genes transcribed from opposite strands.
- Antisense Transcript Identification: Characterizing regulatory antisense RNAs that play critical roles in gene silencing and post-transcriptional regulation.
- Novel Transcript Discovery: Mapping transcription start and end sites with high precision.
- Non-coding RNA Characterization: Differentiating between coding mRNAs and functional long non-coding RNAs (lncRNAs) that share genomic loci.
Kuala Lumpur's Bio-Economic Growth & Genomic Landscape
Kuala Lumpur, the federal capital of Malaysia, has rapidly transformed into a key biotechnology and life sciences hub in Southeast Asia. Under the national framework of the National Biotechnology Policy 2.0, Malaysia has prioritized bio-based innovations to drive economic growth, improve healthcare outcomes, and address agricultural challenges.
The Klang Valley region hosts world-renowned academic and clinical institutions, including Universiti Malaya (UM), Universiti Putra Malaysia (UPM), Universiti Kebangsaan Malaysia (UKM), and the Malaysia Genome and Vaccine Institute (MGVI). These institutions are leading the charge in regional genomic research, creating a growing demand for high-quality, cost-effective transcriptomics services.
By offering localized support and competitive pricing quotes for Stranded mRNA-Seq in Kuala Lumpur, Biomarker Technologies (BMKGene) acts as a critical technological partner for Malaysian researchers, enabling them to publish high-impact studies and accelerate scientific discovery.
Localized Application Scenarios in Malaysia
How directional transcriptomics is driving breakthroughs in Malaysian agriculture, clinical research, and tropical biology.
1. Palm Oil & Agricultural Genomics
As one of the world's leading palm oil producers, Malaysia relies heavily on agricultural biotechnology. Stranded mRNA-Seq is extensively used by local researchers to study the oil palm (Elaeis guineensis). It helps identify regulatory pathways involved in lipid biosynthesis, yield determination, and responses to devastating pathogens like Ganoderma boninense (basal stem rot). Understanding transcriptional directionality is key to identifying non-coding RNAs that regulate disease resistance.
2. Tropical Disease & Virological Studies
Kuala Lumpur's clinical research centers and the Institute for Medical Research (IMR) actively study tropical infectious diseases such as Dengue, Zika, and Tuberculosis. Directional RNA sequencing is vital for host-pathogen transcriptomics, allowing scientists to differentiate between host cellular transcriptomes and viral sense/antisense RNA strands during infection. This maps the viral replication machinery and host immune response pathways with unmatched resolution.
3. Oncology & Precision Medicine
With the rise of oncology clinical trials in major Klang Valley hospitals, stranded transcriptomics has become a cornerstone of biomarker discovery. Researchers use stranded mRNA-Seq to identify novel gene fusions, alternative splicing isoforms, and long non-coding RNAs associated with chemotherapy resistance in local cohorts. This high-resolution data paves the way for personalized therapeutic strategies tailored to Southeast Asian populations.
Our Advanced Sequencing Platforms & Facilities
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics.
Leading, Multi-level High-throughput Sequencing Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Over 20,000 Square Feet Laboratory Space
Our state-of-the-art laboratory features advanced biomolecular laboratory instruments. We operate standard labs of sample extraction, library construction, clean rooms, and sequencing labs. Every step, from sample extraction to sequencing, is performed under strict Standard Operating Procedures (SOPs) to guarantee the highest data quality.
Reliable, Easy-to-use On-line Bioinformatic Analysis Platform
Our self-developed BMKCloud bioinformatics platform features CPUs with 41,104 memory and 3 PB total storage. Backed by 4,260 computing cores with a peak computing power exceeding 121,708.8 Gflop per second, BMKCloud allows researchers to run advanced transcriptomic pipelines, visualize data, and generate publication-ready figures seamlessly.
Fully Automated Platform for Next-Generation Sequencing: Brilliant Lab 1000
Biomarker Technologies (BMKGene) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to our high-throughput NGS library construction service.
By integrating automation, BMKGene strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time.
For our clients in Kuala Lumpur, this translates to faster turnaround times, minimized manual pipetting errors, and consistent, reproducible library preparation—even for low-input or challenging clinical samples.
Enterprise Qualification & Global Standards
Backed by more than 60 national invention patents, 200+ software copyrights, and international ISO quality standards, we deliver reliable genomic solutions on a global scale.
Our Complete Sequencing & Molecular Biology Portfolio
Explore our full suite of sequencing services, supporting clinical diagnostics, agricultural breeding, and basic life sciences in Kuala Lumpur.
